The PepT1 Mechanism: Natural Targeting to Inflamed Gut The most therapeutically significant aspect of KPV's pharmacology for gut health is its interaction with PepT1 (SLC15A1), the intestinal di/tripeptide transporter
American Journal of Health-System Pharmacy , 63 (1), 2630
As always, patients are advised not to start or stop any other prescription drug, over-the-counter product, or supplement without consulting their healthcare provider during sermorelin therapy
Regular IV therapy sessions help maintain optimal nutrient levels and support ongoing health and wellness
Retrieved 3 November 2016
This indicates that DPP-4i treatment is in some cases attempted before switch to GLP-1 RAs, as the cost of DPP-4is is lower, and GLP-1 RAs (during the period in which this study was conducted) required injections